Schwannomatosis
Oncology·MeSH: Schwannomatosis
Prevalence
0.1 / 100K
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Siltuximab | UNITED THERAPEUTICS Corp (UTHR) |
Frequently asked questions
How many drugs are in development for Schwannomatosis?
BioSniper tracks 1 drug in development for Schwannomatosis across 1 company.
How many clinical trials target Schwannomatosis?
There are 2 clinical trials targeting Schwannomatosis tracked by BioSniper.
What is the prevalence of Schwannomatosis?
The estimated prevalence of Schwannomatosis is approximately 0.1 per 100,000 population.
Deep-dive into Schwannomatosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis